MedReleaf Report issue

For profit Phase 2 Phase 3
Founded: Markham ON Canada (2014)
Status: No NME R&D (2014)

Organization Overview

First Clinical Trial
2018
NCT03522467
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

MedReleaf